Murali Janakiram

Murali Janakiram

Albert Einstein College of Medicine - Bronx / United States
Others
AD Scientific Index ID: 4624511
AECOM
person_outline Murali Janakiram's MOST POPULAR ARTICLES
1-) Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trialS Horwitz, OA O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Connor, B Pro, T Illidge, M Fanale, R Advani, NL Bartlett, ...The Lancet 393 (10168), 229-240, 20195002019
2-) Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 studySJ Schuster, CS Tam, P Borchmann, N Worel, JP McGuirk, H Holte, ...The Lancet Oncology 22 (10), 1403-1415, 20213662021
3-) Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label …PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ...The Lancet Oncology 20 (6), 781-794, 20193632019
4-) Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trialMA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ...The Lancet 393 (10168), 253-264, 20192592019
5-) The third group of the B7‐CD 28 immune checkpoint family: HHLA 2, TMIGD 2, B7x, and B7‐H3M Janakiram, UA Shah, W Liu, A Zhao, MP Schoenberg, X ZangImmunological reviews 276 (1), 26-39, 20172412017